Pricing the asset correctly is among the hardest parts of a merger or acquisition. The buyer does not want to pay too much for uncertain results; the seller wants to be rewarded for the future value of the company. In light of increasing innovation dependence within many industries and economic uncertainties extending into 2026, it has gotten much harder to come up with a fair evaluation. It has made firms look into flexible deal terms that share risks but still allow for potential gains.
In this blog post, you will understand what Contingent Value Rights (CVRs) are, why they are relevant to modern mergers and acquisitions, how CVRs are recorded according to U.S. GAAP, what benefits and drawbacks they have, and why businesses use CVRs in acquisition deals.
Understanding Contingent Value Rights and Their Role in M&A
Disagreement about valuation has been the biggest challenge faced by acquiring companies. Although valuation models help predict future performance, many companies generate value through assets that may only be valuable in the event of uncertain future events. Contingent Value Rights provide an effective solution whereby a portion of the cost of acquisition is contingent upon the future outcome.
Why Traditional Valuations Often Fall Short
Assumptions are made concerning the future income of businesses, the demand for their products, regulatory approvals, acceptance among customers, and efficiency. Even though projections help understand how valuable a business could be in the future, they do not remove all uncertainties. The situation is aggravated if an enterprise has assets that have not fully realized their commercial potential.
For instance, a biotech firm may be working on the development of the drug that promises regulatory approval and makes the firm more valuable. An acquirer may consider the chance of getting regulatory approval less probable due to trials and government approval process. There should be a way to address this uncertainty issue.
What Are Contingent Value Rights (CVRs)?
Contingent Value Rights are contract terms under which the buyer will pay further amounts to the shareholders of the target firm contingent upon reaching certain milestones after closing the deal. The milestones can be related to obtaining certain approvals from regulatory authorities, achieving revenues and production levels, launching products, and other business events that occur over a defined period.
Instead of valuing uncertain future events at today's value, CVRs defer the payment of the purchase price contingent on the realization of such events. In this way, buyers mitigate risks and sellers have an opportunity to share in the value created by them.
Why CVRs Have Become More Relevant in 2026
In 2026, the environment for mergers and acquisitions will still be influenced by economic uncertainty, high interest rates, technological development through AI, improvements in the healthcare sector, and changing regulatory frameworks. This has led to increased disagreements regarding valuations and has made flexible acquisition structures a preferred option compared to traditional fixed price acquisitions.
Firms today are also buying companies that possess substantial intangible assets like proprietary software, artificial intelligence algorithms, intellectual property, renewables, and research pipelines. Many of these assets create value in the future, which is why CVRs have gained importance beyond being used exclusively in pharmaceutical acquisitions.
Where CVRs Deliver the Greatest Value
Not every acquisition benefits from contingent consideration. CVRs are particularly effective when future business performance depends on uncertain but measurable events that significantly influence valuation.
Industries Where CVRs Are Commonly Used
The industries of pharmaceuticals and life sciences still make up the largest users of CVRs. Pharmaceutical development takes several years of testing and approvals for bringing out profits. Thus, due to a possible high increase in the value of a business as well as possible total destruction, CVRs will provide an even division of risk between parties.
But by 2026, businesses from such industries as mining, energy, technology, renewable infrastructure, artificial intelligence, and advanced manufacturing will be increasingly utilizing this tool. The milestones of production, the obtaining of patents and licensing, the commercialization of software, and the finding of resources are all cases of uncertain future value.
|
Industry |
Typical CVR Milestone |
|
Pharmaceuticals |
FDA or regulatory approval of a drug |
|
Biotechnology |
Successful completion of clinical trials |
|
Technology |
Commercial launch of AI products or software |
|
Mining |
Achievement of production targets |
|
Renewable Energy |
Completion of major infrastructure projects |
|
Manufacturing |
Meeting operational or revenue milestones |
How CVRs Help Buyers and Sellers Reach Agreement
Acquisitions made in the traditional manner involve having both sides settle on an agreed purchase price even though they have different views regarding this matter. The CVR provides an alternative approach where the purchase price and rewards that come with future success are separated.
The buyer benefits because he is not likely to pay now for something that will never materialize while the seller is not locked out of the chance of getting more money if his expectations are fulfilled in the future.
Comparing Traditional Acquisitions with CVR-Based Transactions
The difference between conventional acquisitions and CVR-based structures highlights why these instruments have gained popularity.
|
Traditional Acquisition |
Acquisition with CVRs |
|
Fixed purchase price |
Initial payment plus contingent payments |
|
Buyer assumes most valuation risk |
Risk shared between buyer and seller |
|
Negotiations may become prolonged |
Easier resolution of valuation disagreements |
|
Limited flexibility |
Highly customizable payment structure |
|
Immediate pricing decisions |
Future performance influences final value |
Accounting, Risks, and the Future of CVRs
While CVRs add flexibility during the negotiating process, they also cause challenges to accounting and reporting processes. Both parties need to know the implications of these derivatives on their financial statements following an acquisition.
Accounting Treatment Under U.S. GAAP
According to ASC 805 – Business Combinations, contingent consideration is initially measured at its fair value on the date of the acquisition. According to the terms of the transaction, the company acquires the CVR as a liability or as an equity instrument.
If CVR is classified as a liability, then it needs to be remeasured on a periodic basis up until the payment is made. The difference in the estimated value of the liability is reflected on the income statement and hence results in volatility in profits. On the other hand, equity CVRs are usually not measured after their initial measurement. The fair value can be estimated using a discounted cash flow approach, probability of payments approach, or the option approach like the Black Scholes model.
Benefits and Challenges of Using CVRs
Apart from solving issues of valuation dispute, CVRs provide strategic advantages in the form of increased deal flexibility, incentive alignment, liquidity preservation for acquirers, and the ability to manage uncertainty while still being able to negotiate.
Yet, there are certain complications that arise along with these advantages. Milestone-based payment is not an easy task from both legal and financial points of view. Calculating the fair value will need sophisticated valuation techniques, and disputes can emerge either due to ambiguous milestones definition or unexpected external impact on performance.
|
Advantages |
Challenges |
|
Bridges valuation gaps |
Complex legal agreements |
|
Encourages successful deal completion |
Difficult valuation assumptions |
|
Preserves buyer liquidity |
Ongoing fair value adjustments |
|
Aligns incentives |
Potential future disputes |
|
Highly customizable |
Increased accounting complexity |
The Future Outlook for CVRs in M&A
Given the growing dependence of business models on intellectual property, digital assets, artificial intelligence, and innovations, there is little hope that valuation uncertainty can be eliminated. On the contrary, it is anticipated that companies will have to resort to flexible transaction designs to combine opportunities and financial prudence.
More and more investment bankers, corporate financiers, and accountants realize the potential of CVRs as an ideal means of structuring acquisitions of innovative and emerging technology businesses or companies that operate in volatile industries. Instead of being a narrowly defined instrument used exclusively by pharmaceutical firms, CVRs are gaining momentum and becoming a broader strategic tool used in M&A all over the world. The growing importance of fair value assessment, proper financial reporting, and incentive deal structure indicates that CVRs will play an important role in acquisitions in the coming years.
CVRs have revolutionized the way companies deal with valuation issues in cases of mergers and acquisitions. By tying a portion of the purchase price to future business success, CVRs allow the buyer to address uncertainties but still give the seller a chance to profit from the future success if certain benchmarks are reached.
Given that the trend of mergers and acquisitions will continue into 2026, companies involved in innovative sectors and those facing uncertain regulations and long lead times are likely to employ CVRs. Despite the need for good valuation, accountancy skills, and clear contractual agreements, this is one of the most viable ways of settling valuation issues.
Follow The Fino Partners for expert insights on accounting, bookkeeping, taxation, corporate finance, regulatory developments, and the latest business trends. Explore our resources to stay ahead of important financial changes and make confident, well-informed decisions.
